Clinical Trial Update: Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the impact of stopping risedronate after long-term treatment on bone turnover in postmenopausal osteoporosis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal Women With Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-10-26